Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

David Elsley

Tracked across 1 events · 6 articles · First seen Sep 23, 2026 · Last active Sep 23, 2026

Sentiment
10
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Tech
Cardiol Therapeutics Inc. announced on September 23, 2026 that its pivotal Phase III MAVERIC trial of CardiolRx for recurrent pericarditis reached its original 110-patient enrollment target ahead of end-of-September guidance. Following a blinded review showing…
Impact: As President and CEO, he publicly framed the lower-than-expected recurrence rate as encouraging and explained the rationale for expanding enrollment to preserve statistical power.
Sep 23, 2026 · 6 articles
ERGEN INTELLIGENCE
Track David Elsley live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.